Thymosin Alpha-1 / KPV / LL-37 Blend

This multi-peptide formulation combines three well-characterized sequences—Thymosin Alpha-1 (Ta1), KPV, and LL-37—selected for their complementary roles in immune system signaling, inflammatory modulation, and innate host defense pathways. Each peptide in this blend has been studied for its unique influence on immune balance and tissue-level response, making the combination a targeted tool for research applications focused on immune resilience, epithelial integrity, and inflammatory regulation. Thymosin Alpha-1 (Ta1) A thymic peptide involved in immune system signaling, Ta1 has been widely studied for its role in T-cell maturation and activation, immune system modulation under stress conditions, and support of adaptive immune response signaling. KPV (Lys-Pro-Val) A tripeptide fragment derived from a-MSH, KPV is recognized for its anti-inflammatory properties, particularly within cytokine signaling modulation (e.g., TNF-a, IL-6 pathways), gastrointestinal and epithelial inflammatory environments, and localized immune response regulation. LL-37 A human antimicrobial peptide (cathelicidin) involved in innate immune defense, LL-37 has been studied for broad-spectrum antimicrobial activity, biofilm disruption and pathogen defense signaling, and wound environment and tissue remodeling support. COAs: View certificate of analysis on the product pages for Thymosin Alpha-1, KPV, and LL-37